Elizabeth Halkon

Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated

T. Southwood, L. Wedderburn, K. Armon, 2015, Arthritis & rheumatology.

Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

T. Southwood, L. Wedderburn, C. Deakin, 2020, Arthritis Research & Therapy.

Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature

T. Jacques, L. Wedderburn, C. Deakin, 2017, Pediatric Rheumatology.

Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling

T. Southwood, L. Wedderburn, C. Deakin, 2018, Arthritis & rheumatology.

Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study

Michael Browne, Tania Amin, Maria De Iorio, 2018, Arthritis Research & Therapy.

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis

T. Jacques, J. Holton, T. Southwood, 2016, Arthritis & rheumatology.

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis

M. De Iorio, T. Southwood, L. Wedderburn, 2016, Arthritis care & research.

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features

T. Jacques, J. Holton, T. Southwood, 2019, Neuropathology and applied neurobiology.